In this special SciDev.Net debate, panelists considered: Are more men dying of COVID-19 than women? Are women at greater risk of violence in lockdown? In stretched health systems, who will receive priority care and who could miss out? Do diagnostics, treatments and vaccine trials take gender into consideration? Does personal protective equipment keep everyone equally safe? And why is sex disaggregated data central to all these questions?
The expert panel, was moderated by SciDev.Net, on Wednesday, 22 April from 2pm-3pm GMT as we debated why gender analysis must be central in global health emergencies.
- Sarah Hawkes: professor of global public health, University College London Institutional Research Information Service; co-founder and co-director of Global Health 50/50.
- Roopa Dhatt: executive director and co-founder, Women in Global Health; internal medicine physician.
- Giampiero Favato: director, Institute of Leadership and Management in Health, Kingston Business School, Kingston University London; editor of the American Public Library of Science journal PLOS ONE.
- Blessing A. Odogwu: plant science and biotechnology lecturer, University of Port Harcourt; member of the Organization for Women in Science for the Developing World (OWSD).
Original post is available on SciDev.Net.